WayPoint Biomedical Holdings, Inc.
WYPH
$0.0001
$0.000.00%
| 06/30/2006 | 03/31/2006 | ||||
|---|---|---|---|---|---|
| Revenue | -53.13% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -53.13% | -- | |||
| Cost of Revenue | -33.33% | -19.44% | |||
| Gross Profit | -55.17% | 67.59% | |||
| SG&A Expenses | 209.78% | 616.25% | |||
| Depreciation & Amortization | 120.00% | -- | |||
| Other Operating Expenses | -- | 537.50% | |||
| Total Operating Expenses | 198.55% | 426.65% | |||
| Operating Income | -207.85% | -412.64% | |||
| Income Before Tax | -141.10% | -495.89% | |||
| Income Tax Expenses | -145.43% | -- | |||
| Earnings from Continuing Operations | -138.93% | -495.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -138.93% | -495.89% | |||
| EBIT | -207.85% | -412.64% | |||
| EBITDA | -209.18% | -417.27% | |||
| EPS Basic | -59.38% | -- | |||
| Normalized Basic EPS | -108.70% | -- | |||
| EPS Diluted | -59.38% | -- | |||
| Normalized Diluted EPS | -108.70% | -- | |||
| Average Basic Shares Outstanding | 52.36% | -- | |||
| Average Diluted Shares Outstanding | 50.06% | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
